Shan Ahmed Khan

Shan Ahmed Khan is a senior markets reporter at TS2.tech, specializing in stocks, technology and macroeconomic trends. A graduate of the Lahore University of Management Sciences (LUMS), he previously worked in investment research and market analysis. His coverage helps readers understand the key developments influencing global financial markets and emerging industries.

Regencell Bioscience (RGC) Stock Jumps Over 20% on December 4, 2025 as DOJ Probe and Going‑Concern Warning Shadow 2025’s Wildest Rally

Regencell Bioscience (RGC) Stock Jumps Over 20% on December 4, 2025 as DOJ Probe and Going‑Concern Warning Shadow 2025’s Wildest Rally

Regencell Bioscience Holdings Limited is back on traders’ radar. On Thursday, December 4, 2025, RGC shares surged more than 20% intraday, trading in the mid‑teens after yet another volatile session in what has arguably been 2025’s most extreme stock story. Intraday data from several market trackers showed the stock changing hands around $16–17, up roughly 24–31% on the day, with the price swinging between about $13 and over $18 on volume close to 1 million shares. GuruFocus+2StockAnalysis+2
4 December 2025
·
BigBear.ai (BBAI) Stock Jumps on Defense‑AI Hype: Latest Price, Forecast and Dilution Risks as of December 4, 2025

BigBear.ai (BBAI) Stock Jumps on Defense‑AI Hype: Latest Price, Forecast and Dilution Risks as of December 4, 2025

BigBear.ai Holdings, Inc. is back in the spotlight. The defense‑focused artificial intelligence stock is trading near multi‑month highs after a sharp rebound driven by its Ask Sage acquisition, new international deals, and a wave of interest in “mission‑ready” AI for national security. At the same time, investors are wrestling with falling revenue, heavy losses, and a plan to double the company’s authorized share count.
4 December 2025
··
IonQ, Inc. (IONQ) Stock Jumps on Quantum-AI and Defense Deals: December 4, 2025 Outlook

IonQ, Inc. (IONQ) Stock Jumps on Quantum-AI and Defense Deals: December 4, 2025 Outlook

Around midday on December 4, 2025, IonQ, Inc. was trading in the mid‑$50s, up double digits intraday after a string of headlines tying the company to biotech, defense drones, and big institutional money. StockAnalysis shows the shares around $54.20, up about 11%, in early afternoon trading. StockAnalysis+1
4 December 2025
····
AST SpaceMobile (ASTS) Soars as BlueBird 6 Launch Nears: Latest News, Stock Forecasts and Analysis as of 4 December 2025

AST SpaceMobile (ASTS) Soars as BlueBird 6 Launch Nears: Latest News, Stock Forecasts and Analysis as of 4 December 2025

AST SpaceMobile, Inc. is back in the spotlight. The satellite‑to‑smartphone pioneer’s share price has jumped into the low‑$70s, powered by a wave of manufacturing expansion news, a firm launch date for its next‑generation BlueBird 6 satellite, and a string of big‑name carrier deals across the U.S., Europe and the Middle East. Business Wire+1
4 December 2025
··
Accenture (ACN) Stock on December 4, 2025: AI Restructuring, OpenAI Deal and 2026 Forecasts Explained

Accenture (ACN) Stock on December 4, 2025: AI Restructuring, OpenAI Deal and 2026 Forecasts Explained

New York, December 4, 2025 — Accenture plc is deep into a self‑described “reinvention” built around artificial intelligence at the same time its stock is still well below last year’s peak. On Thursday, Accenture shares were trading around $271.47, giving the company a market capitalization of roughly $168.5 billion, with a trailing P/E ratio of about 22.3 and a dividend yield near 2.4%.Google
4 December 2025
··
Incannex Healthcare (IXHL) Stock Soars on FDA Fast Track: December 2025 Outlook, Forecast & Key Risks

Incannex Healthcare (IXHL) Stock Soars on FDA Fast Track: December 2025 Outlook, Forecast & Key Risks

Incannex Healthcare Inc. is back on traders’ radar after the U.S. Food and Drug Administration granted Fast Track designation to its lead sleep-apnoea drug candidate, IHL‑42X. The move caps a busy 2025 that also brought strong Phase 2 data in sleep apnoea and psilocybin-assisted therapy, a major clean-up of warrant overhang, and a fight to keep the company’s Nasdaq listing alive. SEC+1
4 December 2025
·
KALA BIO (KALA) Stock Explodes on Oxford Deal and $10M Offering: What December 4, 2025 Means for Investors

KALA BIO (KALA) Stock Explodes on Oxford Deal and $10M Offering: What December 4, 2025 Means for Investors

As of December 4, 2025, KALA BIO, Inc. has turned into one of the wildest tickers on the Nasdaq. The stock is trading around $1.40 in heavy volume, up roughly 50% on the day after a cascade of news: a $10 million registered direct offering, a loan settlement that turns lender Oxford Finance into a 16.5% shareholder, and a $6 million rescue-style preferred investment from new CEO David Lazar. All this arrives barely two months after KALA’s lead drug failed a key trial, its lender swept most of its cash, and management warned of “substantial doubt” about its ability to survive as a going concern. GlobeNewswire+3Stock Titan+3Stock Titan+3
4 December 2025
·
Applied Materials (AMAT) Stock Near Record Highs as TD Cowen Sets $315 Target and Analysts Double Down on AI, DRAM and TSMC Upside

Applied Materials (AMAT) Stock Near Record Highs as TD Cowen Sets $315 Target and Analysts Double Down on AI, DRAM and TSMC Upside

Applied Materials is ending 2025 with the kind of momentum most semiconductor names can only envy. The chip-equipment giant’s shares are trading around all‑time highs in the high‑$260s/low‑$270s, up roughly 60% year‑to‑date after a powerful seven‑session winning streak. Seeking Alpha+2Morningstar+2
4 December 2025
····
1 … 556 557 558 559 560 … 607

Stock Market Today

  • Dollar Slips as Oil Sinks and Geopolitical Risks Ease
    July 27, 2026, 12:43 PM EDT. The dollar index (DXY00) slipped -0.02% as diminished Middle East tensions curbed safe-haven flows. A sharp -6% fall in WTI crude oil weighed on inflation forecasts and further pressured the greenback. US Jun capital goods orders climbed +0.9% m/m, reflecting ongoing economic resilience. The euro strengthened against the dollar, lifted by a five-month peak in Germany's IFO index and hawkish ECB rhetoric. USD/JPY nudged upward amid lingering intervention chatter and subdued Japanese economic indicators.